BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Gadiparthi C, Cholankeril G, Perumpail BJ, Yoo ER, Satapathy SK, Nair S, Ahmed A. Use of direct-acting antiviral agents in hepatitis C virus-infected liver transplant candidates. World J Gastroenterol 2018; 24(3): 315-322 [PMID: 29391754 DOI: 10.3748/wjg.v24.i3.315]
URL: https://www.wjgnet.com/1007-9327/full/v24/i3/315.htm
Number Citing Articles
1
Fabio Baganate, Eliza W. Beal, Dmitry Tumin, Daniel Azoulay, Khalid Mumtaz, Sylvester M. Black, Kenneth Washburn, Timothy M. Pawlik. Early mortality after liver transplantation: Defining the course and the causeSurgery 2018; 164(4): 694 doi: 10.1016/j.surg.2018.04.039
2
Soumya Murag, Brittany B. Dennis, Donghee Kim, Aijaz Ahmed, George Cholankeril. Recent advances in liver transplantation with HCV seropositive donorsF1000Research 2019; 8: 2151 doi: 10.12688/f1000research.20387.1
3
Benoît Dupont, Arnaud Alves. How to manage a patient with chronic liver disease undergoing colorectal surgery?Seminars in Colon and Rectal Surgery 2023; 34(4): 100986 doi: 10.1016/j.scrs.2023.100986
4
Khaled Mohamed Amin Elzorkany, Mahmoud Abd-Elaziz Kora, Aliaa Sabry Abdel Wahed, Hassan El-Sayed Zaghla, Ahmed Mohamed Zahran, Yassein Salah Yassein, Asmaa Zaki El Naggar, Abdallah Essa, Abdelnaser Abdelaty Gadallah. <p>Assessment of Renal Function in Post-Liver Transplant HCV-Positive Patients Treated with Direct Acting Antivirals</p>International Journal of Nephrology and Renovascular Disease 2020; : 351 doi: 10.2147/IJNRD.S275721
5
V. I. Reshetnyak, I. V. Maev, T. M. Reshetnyak, S. V. Zhuravel, V. M. Pisarev. Liver Diseases and the Hemostasis (Rewiew) Part 1. Non-Cholestatic Diseases of the Liver and HemostasisGeneral Reanimatology 2019; 15(5): 74 doi: 10.15360/1813-9779-2019-5-74-87
6
Jérôme Dumortier, Olivier Boillot. Spontaneous Hepatitis C Virus Clearance in a Liver Transplant Recipient After Conversion From Tacrolimus to EverolimusExperimental and Clinical Transplantation 2022; 20(9): 883 doi: 10.6002/ect.2022.0168
7
Justin A Steggerda, Krishnaraj Mahendraraj, Tsuyoshi Todo, Mazen Noureddin. Clinical considerations in the management of non-alcoholic steatohepatitis cirrhosis pre- and post-transplant: A multi-system challengeWorld Journal of Gastroenterology 2020; 26(28): 4018-4035 doi: 10.3748/wjg.v26.i28.4018
8
D.A. Axelrod, M.A. Schnitzler, T. Alhamad, F. Gordon, R.D. Bloom, G.P. Hess, H. Xiao, M. Nazzal, D.L. Segev, V.R. Dharnidharka, A.S. Naik, N.N. Lam, R. Ouseph, B.L. Kasiske, C.M. Durand, K.L. Lentine. The impact of direct-acting antiviral agents on liver and kidney transplant costs and outcomesAmerican Journal of Transplantation 2018; 18(10): 2473 doi: 10.1111/ajt.14895
9
Joanna Musialik, Aureliusz Kolonko, Katarzyna Kwiecień, Aleksander J. Owczarek, Andrzej Więcek. Effectiveness and safety of sofosbuvir‐based therapy against chronic hepatitis C infection after successful kidney transplantationTransplant Infectious Disease 2019; 21(3) doi: 10.1111/tid.13090
10
Nicolas Golse, Pablo Duarte, Andrea Fontana, Cristiane Bündchen, Vincent Karam, M.-A. Allard, Gabriella Pittau, Oriana Ciacio, J.-C. Duclos-Vallée, A. Sa Cunha, Denis Castaing, Daniel Cherqui, René Adam, Didier Samuel, Eric Vibert. Comparative analysis of outcomes after liver resection and liver transplantation for early stages hepatocellular carcinoma in HIV-infected patients. An intention-to-treat analysisHPB 2020; 22(6): 900 doi: 10.1016/j.hpb.2019.10.014
11
Neha Jakhete, Rati Deshpande, Mary G. Bowring, Jessica Shay, Jennifer Katzianer, Shanti Seaman, Ahmet Gurakar, Christine M. Durand, Brittany Barnaba, Kirti Shetty. Effect of Direct-Acting Antiviral Treatment on Decompensated Hepatitis C Virus CirrhosisCurrent Medical Issues 2021; 19(3): 151 doi: 10.4103/cmi.cmi_35_21
12
Nguyen Hai Nam, Kojiro Taura, Siyuan Yao, Toshimi Kaido, Yusuke Uemoto, Yusuke Kimura, Takayuki Anazawa, Ken Fukumitsu, Takashi Ito, Shintaro Yagi, Naoko Kamo, Koichiro Hata, Shinji Uemoto. Pretransplantation splenomegaly frequently persists after liver transplantation and can manifest as hypersplenism and graft fibrosis ‐ a retrospective studyTransplant International 2020; 33(12): 1807 doi: 10.1111/tri.13761
13
Kira L. Newman, Kay M. Johnson, Paul B. Cornia, Peter Wu, Kamal Itani, George N. Ioannou. Perioperative Evaluation and Management of Patients With Cirrhosis: Risk Assessment, Surgical Outcomes, and Future DirectionsClinical Gastroenterology and Hepatology 2020; 18(11): 2398 doi: 10.1016/j.cgh.2019.07.051